Cargando…
Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497276/ https://www.ncbi.nlm.nih.gov/pubmed/28785692 http://dx.doi.org/10.1016/j.ijcha.2015.06.002 |
| _version_ | 1783248130967339008 |
|---|---|
| author | Yamamoto, Eiichiro Ohba, Keisuke Hirata, Yoshihiro Tokitsu, Takanori Fujisue, Koichiro Sugamura, Koichi Kaikita, Koichi Hokimoto, Seiji Sugiyama, Seigo Ogawa, Hisao |
| author_facet | Yamamoto, Eiichiro Ohba, Keisuke Hirata, Yoshihiro Tokitsu, Takanori Fujisue, Koichiro Sugamura, Koichi Kaikita, Koichi Hokimoto, Seiji Sugiyama, Seigo Ogawa, Hisao |
| author_sort | Yamamoto, Eiichiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5497276 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54972762017-08-07 Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study Yamamoto, Eiichiro Ohba, Keisuke Hirata, Yoshihiro Tokitsu, Takanori Fujisue, Koichiro Sugamura, Koichi Kaikita, Koichi Hokimoto, Seiji Sugiyama, Seigo Ogawa, Hisao Int J Cardiol Heart Vasc Article Elsevier 2015-06-16 /pmc/articles/PMC5497276/ /pubmed/28785692 http://dx.doi.org/10.1016/j.ijcha.2015.06.002 Text en © 2015 The Authors. Published by Elsevier Ireland Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Article Yamamoto, Eiichiro Ohba, Keisuke Hirata, Yoshihiro Tokitsu, Takanori Fujisue, Koichiro Sugamura, Koichi Kaikita, Koichi Hokimoto, Seiji Sugiyama, Seigo Ogawa, Hisao Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title | Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title_full | Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title_fullStr | Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title_full_unstemmed | Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title_short | Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study |
| title_sort | olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — orion study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497276/ https://www.ncbi.nlm.nih.gov/pubmed/28785692 http://dx.doi.org/10.1016/j.ijcha.2015.06.002 |
| work_keys_str_mv | AT yamamotoeiichiro olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT ohbakeisuke olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT hiratayoshihiro olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT tokitsutakanori olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT fujisuekoichiro olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT sugamurakoichi olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT kaikitakoichi olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT hokimotoseiji olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT sugiyamaseigo olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy AT ogawahisao olmesartanreversesnotonlyvascularendothelialdysfunctionbutcardiacdiastolicdysfunctioninhypertensivepatientswithheartfailurewithpreservedejectionfractionorionstudy |